Views & Analysis A life sciences vision to deliver health, wealth and resilie... The ABPI’s chief executive Dr Richard Torbett outlines a new ‘vision’ and
News Aldeyra’s reproxalap for dry eye disease accepted by FDA Biotech Aldeyra Therapeutics has announced that the US Food and Drug Administration (FDA) has accepted its New D
News Welcome to the new pharmaphorum Our website has served us well over the years, but after five years since the last re-design – during which aesthetic standards have changed and website technology has improved
